关注
Friedrich Scheiflinger
Friedrich Scheiflinger
Executive Vice President, General Manager Evotec Gene Therapy, Austria
在 evotec.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses
G Antoine, F Scheiflinger, F Dorner, FG Falkner
Virology 244 (2), 365-396, 1998
6951998
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases
F Fakhouri, JP Vernant, A Veyradier, M Wolf, G Kaplanski, R Binaut, ...
Blood 106 (6), 1932-1937, 2005
3672005
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases
M Rieger, PM Mannucci, JAK Hovinga, A Herzog, G Gerstenbauer, ...
Blood 106 (4), 1262-1267, 2005
3502005
Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic …
S Ferrari, F Scheiflinger, M Rieger, G Mudde, M Wolf, P Coppo, JP Girma, ...
Blood 109 (7), 2815-2822, 2007
3072007
von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke
BQ Zhao, AK Chauhan, M Canault, IS Patten, JJ Yang, M Dockal, ...
Blood, the Journal of the American Society of Hematology 114 (15), 3329-3334, 2009
2982009
Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)
B Plaimauer, K Zimmermann, D Völkel, G Antoine, R Kerschbaumer, ...
Blood, The Journal of the American Society of Hematology 100 (10), 3626-3632, 2002
2962002
Nonneutralizing IgM and IgG antibodies to von Willebrand factor–cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura
F Scheiflinger, P Knöbl, B Trattner, B Plaimauer, G Mohr, M Dockal, ...
Blood 102 (9), 3241-3243, 2003
2892003
Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura
C Klaus, B Plaimauer, JD Studt, F Dorner, B Lämmle, PM Mannucci, ...
Blood 103 (12), 4514-4519, 2004
2622004
ADAMTS13: a new link between thrombosis and inflammation
AK Chauhan, J Kisucka, A Brill, MT Walsh, F Scheiflinger, DD Wagner
The Journal of experimental medicine 205 (9), 2065-2074, 2008
2612008
Systemic antithrombotic effects of ADAMTS13
AK Chauhan, DG Motto, CB Lamb, W Bergmeier, M Dockal, B Plaimauer, ...
The Journal of experimental medicine 203 (3), 767-776, 2006
2602006
Flow-induced elongation of von Willebrand factor precedes tension-dependent activation
H Fu, Y Jiang, D Yang, F Scheiflinger, WP Wong, TA Springer
Nature communications 8 (1), 324, 2017
2082017
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
S Ferrari, GC Mudde, M Rieger, A Veyradier, JAK Hovinga, F Scheiflinger
Journal of Thrombosis and Haemostasis 7 (10), 1703-1710, 2009
2082009
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
SFJ Whelan, CJ Hofbauer, FM Horling, P Allacher, MJ Wolfsegger, ...
Blood, The Journal of the American Society of Hematology 121 (6), 1039-1048, 2013
2062013
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
JD Studt, JAK Hovinga, G Antoine, M Hermann, M Rieger, F Scheiflinger, ...
Blood 105 (2), 542-544, 2005
1972005
Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
B Plaimauer, JAK Hovinga, C Juno, MJ Wolfsegger, S Skalicky, ...
journal of Thrombosis and Haemostasis 9 (5), 936-944, 2011
1802011
ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice
F Denorme, F Langhauser, L Desender, A Vandenbulcke, H Rottensteiner, ...
Blood, The Journal of the American Society of Hematology 127 (19), 2337-2345, 2016
1702016
Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
MAH Sonneveld, MPM de Maat, MLP Portegies, M Kavousi, A Hofman, ...
Blood, The Journal of the American Society of Hematology 126 (25), 2739-2746, 2015
1612015
The mystery of antibodies against polyethylene glycol (PEG)-what do we know?
C Lubich, P Allacher, M de la Rosa, A Bauer, T Prenninger, FM Horling, ...
Pharmaceutical research 33, 2239-2249, 2016
1592016
Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice
SF De Meyer, AS Savchenko, MS Haas, D Schatzberg, MC Carroll, ...
Blood, The Journal of the American Society of Hematology 120 (26), 5217-5223, 2012
1582012
Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement
M Noris, S Bucchioni, M Galbusera, R Donadelli, E Bresin, F Castelletti, ...
Journal of the American Society of Nephrology 16 (5), 1177-1183, 2005
1542005
系统目前无法执行此操作,请稍后再试。
文章 1–20